INFINANT HEALTH

Dead / Abandoned — Abandoned — no statement of use filed (as of 15 Jul 2024)

What this means for you

This application is over — abandoned 15 Jul 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
97590576
Mark type
Design + words
Filed
14 Sept 2022
Published for opposition
17 Oct 2023
Abandoned
15 Jul 2024
Attorney of record
John Gary Maynard, III

Goods and services

  • Class 042 — Scientific and technological services: Developing microbiome preparations for foods and medicines for use by mother and infant pairs; developing microbiome preparations for use in treating patients with atopic, allergic, inflammation, inflammatory conditions, infections, autoimmune, cognitive, metabolic disorders and diseases; development of microbiome preparations for pregnant women; development of microbiome preparations for the prevention and treatment of autism; development of microbiome preparations for older adults, elderly; Pharmaceutical and non-pharmaceutical product research and development; product research and development of medicines, nutritional and dietary supplements; Development of computer platforms technology for discovery and development of therapeutics for the treatment, prevention, palliation, and diagnosis of diseases; Research and development of products for the diagnosis of human disease or human health-related conditions; Research of non-pharmaceutical and pharmaceutical products for the prevention or treatment of human diseases or human health-related conditions; Development of computer platforms for discovery and development of research for therapeutics products for the reduction of risk, diagnosis, prevention, palliation, or treatment of human diseases or human health-related conditions; Medical and scientific research in the field(s) of infant gut microbiome health, maternal-infant health and wellness, infant health and wellness, preterm infant health and wellness; Research and development in the field(s) of maternal health, infant health, preterm infant health, gut health, immune health, namely, vaccine efficiency, and metabolic health; Biomedical research services related to health and clinical status of pregnant women, preterm infants, term infants, toddlers and children; Research and development of diagnostics for biological, behavioral, auditory, and pictorial health indicators; Medical and bioscience research services in the areas of the microbiome, immune system, metabolic systems of pregnant women, preterm infants, term infants, toddlers and children; Medical and bioscience research services in to the areas of the microbiome, immune system, and metabolic systems of older adults and elderly; Platform as a service (PAAS) featuring predictive, monitoring and diagnostic computer software platforms for caregivers and healthcare providers to monitor health and wellness of pregnant women, nursing mothers, caregivers, and their infants; development of consumer devices for recording and monitoring health attributes to work in conjunction with or related to live bacterial therapeutics or food products; Development of tools for measuring and tracking infant health data for purposes of evaluating effectiveness of treatment of diseases and medical conditions; Development of maternal and infant wellness tests and applications; Development of Software as a Medical Device (SaMD); Development of Machine Learning as a Medical Device (MLaMD); Development of downloadable mobile applications for monitoring, managing, and treating medical conditions and diseases

Owner

Prosecution history

  • 15 Jul 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
  • 15 Jul 2024 — ABANDONMENT - NO USE STATEMENT FILED
  • 12 Dec 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 17 Oct 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 17 Oct 2023 — PUBLISHED FOR OPPOSITION
  • 27 Sept 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 09 Sept 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 08 Sept 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 08 Sept 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 08 Sept 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 08 Jun 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 08 Jun 2023 — NON-FINAL ACTION E-MAILED
  • 08 Jun 2023 — NON-FINAL ACTION WRITTEN
  • 08 Jun 2023 — ASSIGNED TO EXAMINER
  • 17 Feb 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

View this trademark record on Marksy